Monte Rosa Correlations

GLUE Stock  USD 5.67  0.16  2.74%   
The current 90-days correlation between Monte Rosa Therapeutics and Lyell Immunopharma is 0.09 (i.e., Significant diversification). The correlation of Monte Rosa is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Monte Rosa Correlation With Market

Modest diversification

The correlation between Monte Rosa Therapeutics and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Monte Rosa Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Moving together with Monte Stock

  0.64CRNX Crinetics PharmaceuticalsPairCorr

Moving against Monte Stock

  0.42PLX Protalix BiotherapeuticsPairCorr
  0.4MLSS Milestone Scientific Earnings Call This WeekPairCorr
  0.34GE GE AerospacePairCorr
  0.53CVX Chevron CorpPairCorr
  0.45MMM 3M CompanyPairCorr
  0.34CSCO Cisco SystemsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
IKNAGBIO
IKNAHOWL
GBIONKTX
IKNANKTX
HOWLGBIO
HOWLNKTX
  
High negative correlations   
DSGNSANA
STTKGBIO
HOWLSANA
STTKSTOK
SANAGBIO
IKNASANA

Risk-Adjusted Indicators

There is a big difference between Monte Stock performing well and Monte Rosa Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Monte Rosa's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NKTX  3.17 (0.49) 0.00 (0.59) 0.00 
 7.33 
 20.80 
LYEL  4.16 (0.09) 0.00 (0.10) 0.00 
 7.69 
 29.45 
GBIO  3.80 (1.11) 0.00 (0.85) 0.00 
 7.41 
 22.69 
SANA  7.58  1.60  0.22  0.58  6.09 
 10.15 
 178.30 
DSGN  4.10 (0.19) 0.00 (0.23) 0.00 
 8.72 
 24.91 
HOWL  2.78 (0.48) 0.00 (0.45) 0.00 
 6.08 
 23.66 
IKNA  2.07 (0.18) 0.00 (0.44) 0.00 
 4.65 
 16.13 
STOK  3.45 (0.43) 0.00 (0.31) 0.00 
 7.03 
 20.29 
FHTX  3.69 (0.22) 0.00 (0.14) 0.00 
 9.05 
 26.22 
STTK  5.18  0.47  0.06  0.66  6.44 
 11.21 
 50.15 

Monte Rosa Corporate Management

Filip MDChief OfficerProfile
Jennifer ChampouxVP OperationsProfile
Sharon TownsonChief OfficerProfile
Edmund DunnSenior ControllerProfile
John CastleChief ScientistProfile
Magnus DPHILSenior DevelopmentProfile